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Background: In Escherichia coli phosphoenolpyruvate (PEP) is a key central metabolism intermediate that
participates in glucose transport, as precursor in several biosynthetic pathways and it is involved in allosteric
regulation of glycolytic enzymes. In this work we generated W3110 derivative strains that lack the main PEP
consumers PEP:sugar phosphotransferase system (PTS-) and pyruvate kinase isozymes PykA and PykF
(PTS- pykA- and PTS- pykF -). To characterize the effects of these modifications on cell physiology, carbon flux
distribution and aromatics production capacity were determined.
Results: When compared to reference strain W3110, strain VH33 (PTS-) displayed lower specific rates for growth,
glucose consumption and acetate production as well as a higher biomass yield from glucose. These phenotypic
effects were even more pronounced by the additional inactivation of PykA or PykF. Carbon flux analysis revealed
that PTS inactivation causes a redirection of metabolic flux towards biomass formation. A cycle involving PEP
carboxylase (Ppc) and PEP carboxykinase (Pck) was detected in all strains. In strains W3110, VH33 (PTS-) and VH35
(PTS-, pykF-), the net flux in this cycle was inversely correlated with the specific rate of glucose consumption and
inactivation of Pck in these strains caused a reduction in growth rate. In the PTS- background, inactivation of PykA
caused a reduction in Ppc and Pck cycling as well as a reduction in flux to TCA, whereas inactivation of PykF
caused an increase in anaplerotic flux from PEP to OAA and an increased flux to TCA. The wild-type and mutant
strains were modified to overproduce L-phenylalanine. In resting cells experiments, compared to reference strain,
a 10, 4 and 7-fold higher aromatics yields from glucose were observed as consequence of PTS, PTS PykA and PTS
PykF inactivation.
Conclusions: Metabolic flux analysis performed on strains lacking the main activities generating pyruvate from PEP
revealed the high degree of flexibility to perturbations of the central metabolic network in E. coli. The observed
responses to reduced glucose uptake and PEP to pyruvate rate of conversion caused by PTS, PykA and PykF
inactivation included flux rerouting in several central metabolism nodes towards anabolic biosynthetic reactions,
thus compensating for carbon limitation in these mutant strains. The detected cycle involving Ppc and Pck was
found to be required for maintaining the specific growth and glucose consumption rates in all studied strains.
Strains VH33 (PTS-), VH34 (PTS- pykA-) and VH35 (PTS- pykF-) have useful properties for biotechnological processes,
such as increased PEP availability and high biomass yields from glucose, making them useful for the production of
aromatic compounds or recombinant proteins.
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Escherichia coli is a fast growing microorganism that
can be modified by a wide variety of molecular tools,
thus enabling the generation of industrial strains for the
production of metabolites and recombinant proteins.
This bacterium can grow in defined media using glucose
as sole carbon source, and under this condition, central
metabolism is mainly constituted by the Embden-
Meyerhof-Parnas (EMP) pathway, the pentose phosphate
pathway (PPP) and the tricarboxylic acid (TCA) cycle.
Together, these three pathways provide energy (ATP,
GTP), reducing power (NADH, NADPH, FADH2) and
biomass precursors for the cell [1]. When E. coli grows
on glucose as carbon source, this sugar is imported by
the phosphoenolpyruvate (PEP):sugar phosphotransfer-
ase system (PTS) that couples the transfer of the phos-
phate group from PEP to this sugar, thus generating as
products glucose 6-phosphate (G6P) and pyruvate (PYR)
[2-4] (Figure 1). In E. coli, PEP also participates as sub-
strate in the reaction catalyzed by the pyruvate kinase
(Pyk) isozymes (PykA and PykF), yielding PYR and ATP
[5]. Furthermore, PEP connects the EMP pathway and
the TCA cycle via an anaplerotic reaction catalyzed by
PEP carboxylase (Ppc) that generates oxaloacetate
(OAA) [6,7]. During gluconeogenic metabolism PEP syn-
thase (Pps) converts PYR to PEP and PEP carboxykinase
(Pck) forms PEP from OAA [7,8]. In addition to its par-
ticipation in metabolic reactions, PEP also plays a regu-
latory role. An inhibitory effect of PEP has been
described on the EMP pathway enzymes glucokinase
(Glk), phosphoglucoisomerase (Pgi), phosphofructoki-
nase (Pfk) and aldolase (FbaA) [9] whereas an activation
effect has been described in the enzymes phosphate
acetyltransferase (Pta) and acetate kinase (Aks) [10]
(Figure 1).
The first step in the common aromatic pathway or shi-
kimate (SHIK) pathway consists in the condensation of
PEP and erythrose 4 phosphate (E4P) to yield 3-deoxy-
D-arabinoheptulosonate 7 phosphate (DAHP). In E. coli,
this reaction is catalyzed by the DAHP synthase isozymes
(AroF, AroG and AroH) [11] (Figures 1 and 2b). Within
this pathway, the synthesis of dehydroshikimate (DHS) to
yield SHIK, a reaction catalyzed by the enzyme SHIK de-
hydrogenase (AroE), is a step that requires reducing power
in the form of NADPH. An additional PEP molecule is
required to condense with SHIK-3-phosphate (S3P) to yield
5-enol-pyruvylshikimate-3-phosphate (EPSP) by the en-
zyme EPSP synthase (AroA) [12]. The final product of the
SHIK pathway is chorismate (CHO), a precursor molecule
for the synthesis of the aromatic amino acids tryptophan
(TRP), tyrosine (TYR) and phenylalanine (PHE) [13]
(Figure 2b). The PHE biosynthetic pathway starts with the
conversion of CHO to prephenate and subsequently to
phenylpyruvate (PPY) by the bifunctional enzyme CHOmutase-prephenate dehydratase (CM-PDT), encoded by
gene pheA. In the last step of this pathway, the enzyme
PHE aminotransferase (TyrB) transfers an amino group
from glutamate to PPY to yield PHE (Figure 2b).
The aromatic amino acids and some intermediates of
the SHIK pathway are metabolites having industrial
applications [14-19]. These include the aromatic amino
acid PHE as precursor of the low-calorie sweetener as-
partame, L-3,4-dihydroxyphenylalanine (L-DOPA) used
for treatment of Parkinson's disease [20] and the inter-
mediate SHIK as precursor of the antiviral osetalmivir
[21,22]. Several reports indicate that PEP availability is
one of the main factors to be considered when designing
a strategy to generate aromatics production strains
[19,23,24]. In this regard, PTS, PykA and PykF, as the
main PEP consuming reactions in E. coli, have been the
subject of several studies to understand their role on the
cell’s physiology [25-29]. In E. coli, PTS is the main PEP-
consuming activity during growth on glucose [2-4]. For
this reason, PTS can be considered the most promising
cellular target to inactivate in order to increase PEP
availability and therefore, aromatics yield from glucose
[15]. A mutant strain lacking PTS activity (PTS-) dis-
plays poor growth on glucose (PTS- glc- phenotype)
which is clearly an undesirable trait in the context of an in-
dustrial production process. To improve the characteristics
of a PTS- glc- strain, a chemostat selection method was
employed, thereby it was possible to isolate mutants that
display rapid growth on glucose (PTS- glc+ phenotype) [30].
Characterization of one of such mutants revealed that glu-
cose import and phosphorylation are dependent on the
GalP symporter and glucokinase (Glk), respectively [27,31]
(Figure 1). This mutant was modified for aromatics produc-
tion and it was determined that it can produce PHE with a
higher yield from glucose when compared to an isogenic
PTS+ strain [23,30,32].
In E. coli the total Pyk activity is dependent on the PykA
and PykF isozymes which constitute the second main PEP-
consuming activity in the cell [5,33-35]. These isozymes are
encoded by genes pykA and pykF, whereby pykF is regulated
by the catabolite repressor/activator protein (Cra) [36,37].
It has recently been demonstrated that pykA might also be
regulated by Cra [38]. Both Pyk isozymes are subject to
metabolic control of enzyme activity. The enzyme PykF is
activated by fructose-1, 6-bisphosphate (FBP), whereas
ATP, GTP and succinyl coenzyme A (SUCC CoA) are
negative effectors [36,39-44]. The enzyme PykA is activated
by adenosine monophosphate (AMP) and sugars from the
PPP (gluconate 6-phosphate, ribose 5-phosphate, ribu-
lose 5-phosphate, heptulosonate 7-phosphate and xylulose
5-phosphate) whereas SUCC CoA is a negative effector
[45,46]. It has been observed in E. coli that PykF displays
the highest enzyme activity when compared to PykA in
wild type as well as the PTS- background during growth on
Figure 1 Central carbon metabolism pathways in E. coli. The Embden-Meyerhof-Parnas (EMP), pentose phosphate pathway (PPP) and
tricarboxylic acid cycle (TCA) in E. coli during growth in glucose. In the figure PTS (in blue), the non PTS glucose uptake system (in purple), PEP
node (green) and AAA (yellow) enzymes are depicted. The allosteric effects that PEP has in EMP and acetate biosynthesis are in orange line for
inhibition and blue arrow for activation.
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PykF is considered the main Pyk activity in E. coli [25,26,29].
Both PykA and PykF are well characterized proteins,
however, their specific roles in central carbon metabolism
are still not completely clear. Carbon flux studies in Pyk de-
ficient E. coli strains have been performed in a genetic back-
ground where PTS is active, therefore, PTS-dependentsynthesis of PYR from PEP is still occurring by this activity
in the mutant strains [25,26,29]. An E. coli strain lacking
PTS activity provides a background where the PEP to PYR
reaction is dependent only on Pyk activity, thus enabling a
study designed to provide further insight into the roles of
PTS, PykA and PykF on central metabolism. The use of
several “omics” tools to unravel E. coli's cellular responses
Figure 2 Aromatic amino acids biosynthesis. a) DHS, SHIK, PHE and (DHS+ SHIK + PHE) yields from glucose. The values shown are the result of
three independent experiments. b) The common aromatic pathway and the final pathways leading to PHE, TYR and TRP.
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important industrial microorganism [25,26,29]. In this work
we used a fluxome [47] approach to describe the pheno-
typic response (carbon fluxes) to the absence of PTS and
also to a condition when the PYR to PEP reaction is
dependent only on PykA or PykF activity.
Methods
Strains and plasmids
The strains used in this work are described in Table 1.
The reference strain E. coli W3110 is an F- λ- galactose
fermenting derivative of E. coli K-12 [48]. Strain VH32 is a
ΔptsI, ptsH, crr::kan ΔlacI, lacZ::loxP (PTS-) derivative of
W3110 displaying a PTS- glc- phenotype [49]. Strain
VH32 galP+ is a derivative of VH32 that was constructed
by replacing the native galactose permease gene (galP)
promoter by the trc promoter [50]. The method employed
for this purpose leaves a stable chloramphenicol (Cm) re-
sistance cassette (cat) flanked by phage λ Red recombinase(FLP) recognition target (FRT) sites [51]. In this strain,
glucose import is dependent on GalP and glucose phos-
phorylation on glucokinase (Glk) activity encoded by the
chromosomal glk gene. Since the lacI gene was deleted in
strain VH32 galP+, expression of galP from the trc pro-
moter is constitutive. To generate strain VH33, the cat re-
sistance cassette was removed from VH32 galP+ by
transforming it with plasmid pCP20 that expresses FLP
[52]. Strains VH34 (ΔptsI, ptsH, crr::kan, pykA::cat) and
VH35 (ΔptsI, ptsH, crr::kan, pykF::aacC1) were generated
by P1 transduction of VH33 using PB28 strain (ΔptsI,
ptsH, crr::kan, pykA::cat, pykF::aacC1) [28] lysate as a
donor and selecting with the corresponding antibiotic:
chloramphenicol (Cm) or gentamicin (Gen). Verification
of the desired genotype was made by PCR; in the case of
pykA interruption by cat the 5’ primer was TGA AGG
AAT CGC GTT TTG ATA and the 3’ primer: GTA TTA
GTA GAA CCC ACG GTA. For verification of pykF inter-
ruption with aacC1 the PCR reaction included the 5’
Table 1 Escherichia coli strains and plasmids used
Strain Description Reference
PB28 ΔptsI, ptsH, crr::kan, pykA::cat, pykF::gen [28]
JM101 pck- SupE, thi, Δ(lac-proAB), F’, pck::cat [53]
W3110 F- λ- INV(rrnD - rrnE)1 [48]
VH32 galP+ W3110 ΔptsH, ptsI, crr::Km, ΔlacI,
lacZ::loxP ΔPgalP::cat,PTrc
[50]
VH33 VH32 galP+ ΔPgalP:: PTrc This work
VH34 VH33 pykA::cat This work
VH35 VH33 pykF::gen This work
W3110 pck- W3110 pck::cat This work
VH33 pck- VH33 pck::cat This work
VH34 pck- VH34 pck::cat This work
VH35 pck- VH35 pck::cat This work
W3110A W3110/JLBaroGfbrtktA, pTrcpheAev2 This work
VH33A VH33/JLBaroGfbrtktA, pTrcpheAev2 This work
VH34A VH34/JLBaroGfbrtktA, pTrcpheAev2 This work
VH35A VH35/JLBaroGfbrtktA, pTrcpheAev2 This work
Plasmids
pCP20 FLP+, λci857+, λ pRRepts, ApR, CmR [52]
pJLBaroGfbrtktA aroGfbr under control of the lacUV5
promoter; and tktA under its native
promoter, carries lacIq and tet genes.
Replication origin from pACYC184
[55]
pTrcpheAev2 Evolved pheAev2 under the control of
lacUV5 promoter. Ev2 superscript means
2nd version of evolved pheAfbr gene.
[32]
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primer: GAG TCC GGC TGA TGT TGG GAG TAG
GTG GCT. pck- derivatives were generated by P1 trans-
duction in W3110, VH33, and VH35 using a JM101 pck-
strain [53] (supE, thi, Δ(lac-proAB), F’, pck::cat) lysate as
donor and selecting with Cm. In these pck- strains the cat
cassette is flanked by FRT sites, so in order to generate
strain VH34 pck-, the cat resistance cassette was removed
from VH33 pck- strain by transforming it with plasmid
pCP20, and then performing P1 transduction in the result-
ing strain using a lysate from PB28 (ΔptsI, ptsH, crr::kan,
pykA::cat, pykF::gen) as a donor. Resulting strain VH33
pck- pykA- (VH34 pck-) strain was selected using medium
with Cm. Verification of the pck::cat mutation in deriva-
tive strains was done by PCR using primers reported else-
were [54] (data not shown). Two plasmids were used in
this work (Table 1). pJLBaroGfbrtktA [55] is a pACYC184
derivative that harbors gene aroGfbr encoding a feedback
resistance version of DAHP synthase. This plasmid also
contains a copy of the gene tktA that encodes transketo-
lase, an enzyme that catalyzes the reversible conversion of
D-fructose-6-phosphate (F6P) and D-glyceraldehyde-5-
phosphate (G5P) into D-xylulose-5-phosphate (XU5P)
and E4P. The aroGfbr gene is under transcriptional controlof the lacUV5 strong promoter that is inducible by iso-
propyl-β-D-thiogalactopyranoside (IPTG), whereas the
tktA gene is under control of its native promoter. Plasmid
pTrcpheAev2 contains a second evolved version of a mu-
tant version of chorismate mutase-prephenate dehydratase
enzyme (PheA) [32]. This gene is under transcriptional
control of the the trc promoter. Strains W3110, VH33,
VH34 and VH35 were sequentially transformed with plas-
mids pJLBaroGfbrtktA and pTrcpheAev2 to generate strains
W3110A, VH33A, VH34A and VH35A, respectively.
Growth media and cultivation conditions
The medium used during mutant strains construction and
selection was Luria-Bertani (LB) with the corresponding
antibiotic: Cm 10 μg/ml, Km 10 μg/ml and Gm 5 μg/ml
(Table 1). In shake flask cultures and labeling experiment,
minimal medium was used. It contained glucose as the
sole carbon source at a concentration of 10 g/l, K2HPO4
90 mM, KH2PO4 10 mM, (NH4)2SO4 40 mM,
NaCl 20 mM, MgSO42H2O 1.6 mM, CaCl2 0.05 mM,
FeSO47H2O 0.072 mM and vitamin B1 0.05 mM. Glucose
and salts solution were sterilized separately at 121°C
during 20 minutes and vitamin B1 was sterilized by filtra-
tion. All stock cultures were stored at −70°C in LB
medium containing glycerol (25% v/v). For fermentation
profiles, 5 ml of LB overnight cultures were used as inocu-
lum, washed twice with minimal medium and then sub-
cultured in shake flask containing 30 ml of minimal
medium with 5 g/l glucose starting with an OD600nm=0.1
and incubated at 37°C, 300 rpm during 12 hours in an or-
bital shaker (G25, New Brunswick Scientific, Inc., New
Brunswick, NJ). These cultures were used to inoculate
30 ml of minimal medium with 10 g/l glucose at an
OD600nm= 0.01 and then incubated at 37°C, 300 rpm dur-
ing 24 hours. Every 2 hours 1 ml of culture was harvested,
OD was determined (Biomate 5, ThermoSpectronic), cells
were centrifuged (10,000 g for 10 min) and the super-
natant used for metabolite determination by HPLC. For
labeling experiments, the naturally labeled glucose was sub-
stituted by 99% [1- 13C] labeled glucose (Cambridge Isotope
Laboratories, Andover, USA). Cells were harvested during
the exponential growth phase at 9 hours (OD600nm=3.72)
for W3110, 15 hours (OD600nm=6.68) for VH33, 16 hours
for VH34 (OD600nm=7.68) and 16 hours for VH35
(OD600nm=5.1). Cultures for determining the correlation
between optical density (600 nm) and cell dry mass
(CDM) were started with 5 ml of LB overnight cultures
that were used as inoculum, washed twice with minimal
medium and then used to inoculate a shake flask con-
taining 50 ml of minimal medium with glucose 5 g/l
starting at an OD600nm = 0.1 and incubated at 37°C,
300 rpm for 12 hours in an orbital shaker. To determine
the correlation between optical density and CDM, 10 ml
of cells grown in minimal medium were harvested and
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water and dried at 80°C until constant weight. The cor-
relation between OD600nm and CDM [g/L] was deter-
mined as CDM=0.45 x OD600nm.
Sample preparation for labeling analysis and estimation
of metabolic flux
The total volume of cultures grown with [1- 13C] labeled
glucose (10 ml) was centrifuged and the pellet (about 1 mg
dry cell mass) was washed twice with cold water (4°C).
Hydrolysis was performed with 50 μL of HCl 6 N at 110°C
for 24 hours. The insoluble debris was separated by filtra-
tion (Titan 2 HPLC filter purple, 0.2 μm nylon membrane,
Sun-Sri), neutralized with NaOH 6 N and lyophilized.
Derivatization with (trimethylsilyl) trifluoroacetamide
(BSTFA) of the lyophilized cell protein was performed to
determine 13C labeling pattern of proteinogenic amino
acids by GC-MS as previously described [56]. The meta-
bolic network for simulation was comprised of the EMP
pathway, the PPP, the TCA cycle and the Ender Duodoroff
pathway. Glyoxylate shunt, anaplerotic reactions and malic
enzyme were included. The simulation was done as previ-
ously described [56].
Resting cells experiments
To determine PHE production and yield in W3110A,
VH33A, VH34A and VH35A strains, a resting cells method
was used. 5 ml of LB overnight cultures were used as in-
oculum, washed twice with minimal medium supplemented
with 10 g/l of yeast extract (MM+YE) and then sub-
cultured in shake flask containing 50 ml of MM+YE with
5 g/l glucose starting with an OD600nm=0.1 and incubated
at 37°C, 300 rpm until optic density of 2.0. At this point,
cells were harvested, washed twice with minimal medium
and suspended in 50 ml of minimal medium with 10 g/l
glucose. To arrest cellular growth 50 μg/ml of chloram-
phenicol was added as well as 100 μM IPTG for aroGfbr
and pheAev2 transcriptional induction. Cell cultures were
incubated during 12 hours in an orbital shaker. Every hour,
1 ml of culture was harvested, OD600nm was determined,
cells were centrifuged (10,000 g for 10 min) and the super-
natant used for metabolite determination by HPLC.
Determination of glucose, organic acids, DHS, SHIK and
PHE
For determination concentrations of D-glucose and or-
ganic acids, an Aminex HPX-87 H column (300 X
7.8 mm; 9 Am Bio-Rad, Hercules, CA) was used. Separ-
ation was carried out isocratically with 5 mM H2SO4 at a
flow rate of 0.5 ml/min and a temperature of 50°C. Under
these conditions glucose was detected by refraction index
and acetic acid, DHS and SHIK by photodiode array at
210 nm. For these measurements a Waters HPLC systemwas used: 600E quaternary pump, 717 automatic injector,
2410 refraction index, and 996 photodiode array.
PHE concentration in culture supernatants was quan-
tified with a Phenomenex Synergy Hydro RP18 column
(150 by 4.6 mm; 4 m) attached to an Agilent 1100 HPLC
system (Agilent Technologies, Palo Alto, CA). Running
conditions were: mobile phase, 0.2% TFA in 40% metha-
nol; flow, 0.5 ml/min. Detection was performed with a
photodiode array at 280 nm.
Determination of Pyk enzyme activity
Cells in exponential growth phase were harvested by cen-
trifugation (10,000 g for 10 min), washed twice with
50 mM sodium phosphate buffer (pH 7.2 at 4°C), sus-
pended in the same buffer, and disrupted by sonication
using four 15-second, λ=10 μm, pulses in a cold bath
(Ultrasonic Disrupter, Soniprep 150). The cell debris was
removed by centrifugation (10,000 g, 10 min, 4°C), and
the resulting crude cell extracts were immediately used to
determine enzyme activities. Pyk enzyme activities were
determined spectrophotometrically (Biomate 5, Thermo-
Spectronic) using 1 U of lactate dehydrogenase (LDH) as
coupling enzyme [57]. The reaction mix contained KCl
50 mM, MgCl2 5 mM, ADP 2 mM, NADH 0.2 mM, PEP
100 mM, fructose-1,6 biphosphate (FBP) 1 mM, AMP
1 mM and ribose-5-phosphate (R5P) 1 mM. One unit of
specific enzyme activity was defined as the amount of en-
zyme required to convert 1 μmol of substrate into the
specific product per minute per milligram of protein at
30°C. Protein concentrations were measured using the
Lowry method. Enzyme activities reported are the average
of three independent experiments.
Results
Pyk mutant strains verification
Strain VH33 is a W3110 mutant derivative lacking PTS ac-
tivity as a result of deleting genes ptsI, ptsH and crr. This
strain was also modified in order to increase its glucose im-
port capacity by replacing the native promoter of gene galP
by the strong trc promoter and inactivating the lacI gene.
As a result of these modifications VH33 displays a constitu-
tive PTS- glc+ phenotype. In this work, strain VH33 was
further modified by inactivating either pykA or pykF, to gen-
erate strains VH34 and VH35, respectively.
Figure 3a depicts the genomic regions of pykA and pykF
and the resulting modifications after interruption with cat
(VH34) or aacC1 (VH35) antibiotic resistance genes. The
forward primer for verification of pykA interruption anneals
outside of the pykA region while the reverse primer binds
at the end of the gene. PCR amplification using genomic
DNA from VH33, VH34 and VH35 as template showed
two expected bands: one of 1.6 kb for VH33 and VH35 and
one of 2.3 kb for VH34 due to the insertion of the cat gene
in the pykA gene (Figure 3b). For verifying strain VH35, the
Figure 3 Mutant strain verification. (a) Chromosomal regions of genes pykA, pykF, pykA::cat and pykF::aacC1. The annealing sites of the primers
employed for strain verification are depicted (green color). (b) Gel electrophoresis of the genomic DNA PCR products of strains VH33 (PTS-), VH34
(PTS- pykA-) and VH35 (PTS- pykA-).
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ing region while the reverse primer binds to the aacC1
gene. When using genomic DNA from VH33, VH34 and
VH35 as template, no PCR product was observed for
VH33 or VH34 while the expected 2 kb band was observed
for VH35 (Figure 3b). These results, together with the
expected antibiotic resistance phenoptypes, indicated that
interruptions of pykA by cat and pykF by aacC1 were
present in VH34 and VH35.
Measurement of Pyk enzyme activity
In the wild type strain W3110 the activities that deter-
mine the PEP! PYR flux are PTS, PykA and PykF, while
in strain VH33 this reaction is catalyzed only by both Pyk
isozymes. In strains VH34 and VH35, the PEP!PYR
reaction is dependent only on PykF or PykA, respectively.
The measured total Pyk enzyme activity (PykA+PykF) in
strain W3110 was 0.18 ± 0.03 U/mg and a similar value
was observed in strain VH33 (Figure 4). In strain VH34,
where only the PykF isozyme is active, the Pyk specificactivity was 0.21 ± 0.01 U/mg, whereas in the VH35
strain the Pyk activity, dependent only on PykA, was
0.05 ± 0.01 U/mg (Figure 4).
Batch culture profiles
To determine the effects on kinetic and stoichiometric
parameters caused by PTS, PTS pykA and PTS pykF inac-
tivations, batch cultures in minimal medium with 10 g/l of
glucose as sole carbon source were performed (Table 2).
Under these conditions, reference strain W3110 displayed
a μ of 0.69 h-1 and a qGlc of 16.1 mmol/g/h; both values
were the highest among the tested strains. A high qAc of
4.31 mmol/g/h was determined and no other by-products
were observed. The biomass yield from glucose (Yx/s) was
52.44 g/ mol, the lowest value observed among strains in
this study. Strain VH33 displayed a μ of 0.45 h-1 and a
specific glucose uptake rate (qGlc) of 6.9 mmol/g/h. The
specific acetate production rate (qAc) was 5% of the value
observed in W3110. When compared to the wild type
strain, the Yx/s in VH33 increased 20%. Deletion of pykA
Figure 4 Metabolic flux distribution and Pyk activity. Metabolic flux distribution and Pyk activities of strains W3110 (reference), VH33
(PTS- glc+), VH34 (PTS- glc+ pykA-) and VH35 (PTS- glc+ pykF -) (from dark to light blue respectively). The figure shows the relative flux of each
strain. Between PEP and PYR nodes a graph bar of Pyk activity is depicted. In parenthesis, next to the strains names, the specific glucose
consumption rates (mmol / g  h) are shown.
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Table 2 Growth kinetic parameters in minimal media
Strain μ (h-1) Yx/s (g / mol) qs (mmol / g / h) YAc/Glc (mol / mol) qAc (mmol / g/ h)
W3110 (WT) 0.69 ± 0.01 52.44 ± 4.42 16.1 ± 0.33 1.2 ± 0.01 4.31 ± 0.12
VH33 (PTS-) 0.45 ± 0.00 63 ± 3.60 6.9 ± 0.61 0.09 ± 0.00 0.23 ± 0.00
VH34 (PTS- pykA-) 0.44 ± 0.00 104.4 ± 16.20 4.2 ± 0.61 – –
VH35 (PTS- pykF-) 0.36 ± 0.01 84.6 ± 9.00 4.2 ± 0.41 – –
W3110 pck- 0.64 ± 0.04 51.76 ± 1.93 12.44 ± 0.23 0.32 ± 0.03 1.14 ± 0.01
VH33 pck- (PTS- pck-) 0.37 ± 0.00 80.47 ± 0.86 4.61 ± 0.09 0.01 ± 0.01 0.03 ± 0.00
VH34 pck- (PTS- pykA- pck-) 0.33 ± 0.02 101.00 ± 2.87 3.35 ± 0.13 – –
VH35 pck- (PTS- pykF- pck-) 0.29 ± 0.00 73.32 ± 2.06 3.96 ± 0.13 – –
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whereas deletion of pykF (VH35) had a negative effect
(0.36 h-1). Both strains showed the same qGlc value
(4.2 mmol/g/h) and no acetate production was detected.
The highest Yx/s value among all tested strains was
observed for strain VH34 (Table 2).
Metabolic flux responses to PTS inactivation
To determine in fine detail the consequences of PTS
and PykA or PykF inactivation on central carbon metab-
olism, 13C metabolic flux analysis was performed. In
reference strain W3110, the EMP pathway was identified
as the main metabolic route involved in glucose catabol-
ism, the PPP had a minor role and the Entner-
Duodoroff pathway (EDP) was hardly active. The TCA
cycle displayed a low carbon flux value and the glyoxy-
late shunt was slightly active (Figure 4). It is noteworthy
that a low level of carbon exchange was detected be-
tween PEP and OAA (catalyzed by Ppc and Pck), form-
ing a cycle where one ATP molecule is hydrolyzed.
PTS inactivation had a strong effect on the metabolic
flux distribution throughout the whole central metabolic
network. The EMP pathway relative flux was reduced
while PPP and TCA cycle fluxes were increased. When
compared to data from strain W3110, an increase in the
exchange rate between PEP and OAA, involving Ppc and
Pck, was observed. Also, strain VH33 displayed higher
carbon flux to biomass when compared to the wild-type
strain. At the lower part of the EMP pathway, the total
PEP!PYR flux decreased from 163% in W3110 to 142%
in VH33; however, the flux dependent only on Pyk iso-
zymes activity increased from 63.8% in W3110 to 142.2%
in the PTS- glc+ strain. The flux from acetyl coenzyme A
(AcCoA) to acetate was reduced from 116% in W3110 to
9% in VH33. When compared to W3110, a 4 fold higher
flux into the TCA was observed in strain VH33.
Metabolic flux responses to Pyk isozyme inactivation in
the PTS- glc+ background.
Inactivation of either Pyk isozyme in the PTS- glc+ back-
ground caused a similar level of reduction in qs and qac,and the magnitude of the flux from PEP to PYR was similar
in both strains. However, values for μ, Yx/s and Pyk activity,
differed between strains VH34 and VH35. Compared to
strain VH34, the anaplerotic flux from PEP to OAA was 3
fold higher in VH35, and the flux directed to the TCA cycle
via GltA was also higher (Figure 4). Flux from AcCoA to
acetate was absent in both strains and the glyoxylate shunt
was found to be active only in VH34. A high carbon ex-
change flux between PEP and OAA was found in VH35,
whereas for VH34 the exchange flux value was the lowest
of all studied strains. When compared to strain VH33, it
was observed that inactivation of either Pyk isozyme caused
an increase in carbon flux directed to biomass formation.
Physiological responses to Pck inactivation
The flux analysis data revealed the existence of a metabolic
cycle involving Ppc and Pck in all studied strains. In order
to gain more insight into the role of this cycle, we generated
pck- mutant derivatives of W3110, VH33, VH34 and VH35.
When these derivative strains were cultured in minimal
medium with glucose as sole carbon source, a reduction in
μ and qs was observed. Also, a 75% and 87% reduction in
the rate of acetate production was observed in strains
W3110 and VH33, respectively (Table 2).
Aromatic amino acids production
The effects of PTS and Pyk inactivation on aromatics
production capacity, was determined on strains W3110A,
VH33A, VH34A and VH35A that carry plasmids
pJLBaroGfbrtktA and pTrcpheAev2 having genes encoding
enzymes that increase carbon flow from central metabol-
ism to the common aromatic and PHE biosynthetic path-
ways. These modifications cause an increase in PHE
production capacity. However, accumulation and secretion
of pathway intermediates such as DHS and SHIK also
occurs as consequence of pathway bottlenecks in the
common aromatic pathway.
Metabolites DHS and SHIK as well as PHE, were
quantified from supernatants of resting cells cultures.
Figure 2a and Table 3 show the calculated yields from
glucose for DHS, SHIK and PHE, as well as the sum of
Table 3 Batch profiles and common shikimate pathway intermediaries and phenylalanine yields from glucose of
W3110A, VH33A, VH34A and VH35A resting cells in minimal media
Strain qs
(mmol / g / h)
qAc









W3110A 2.51 ± 0.10 7.52 ± 0.46 0.01 ± 0.00 0.00 ± 0.00 0.04 ± 0.01 0.05 ± 0.01
VH33A 0.70 ± 0.04 – 0.13 ± 0.03 0.06 ± 0.01 0.25 ± 0.03 0.44 ± 0.06
VH34A 1.96 ± 0.02 – 0.05 ± 0.01 0.04 ± 0.00 0.08 ± 0.00 0.17 ± 0.01
VH35A 0.91 ± 0.04 – 0.24 ± 0.01 0.06 ± 0.00 0.03 ± 0.01 0.33 ± 0.02
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value that includes the sum of the amounts detected for
DHS, SHIK and PHE is the best indicator of aromatics
production capacity, which itself is directly related to
PEP biosynthetic availability. Inactivation of PTS caused
a near 10-fold increase in YDHS+SHIK+PHE/Glc when com-
pared to wild-type strain W3110. This is the result of
replacing PEP-dependent glucose transport in the wild-
type strain by an ATP-dependent mechanism in strain
VH33 [23,30]. In the PTS- glc+ background, inactivation
of PykA (VH34) or PykF (VH35) caused 3.4 and 6.6-fold
increases in YDHS+SHIK+PHE/Glc when compared to
W3110.
Discussion
The objective of the present work consisted on deter-
mining the effects of PTS and Pyk isozymes inactivation
on cell physiology, metabolic flux distribution and PEP
availability for aromatics biosynthesis. The inactivation
of PTS in E. coli abolishes PEP-dependent glucose trans-
port; therefore PYR production from PEP is dependent
only on Pyk isozyme activities. In this study, by inactivat-
ing each Pyk isozyme in a PTS- glc+ background, strains
were generated where the PEP to PYR reaction was
dependent only on PykA or PykF activity. These strains
were characterized by flux analysis, thus providing the
first quantitative description of the metabolic conse-
quences of the sequential elimination of activities cata-
lyzing the PEP to PYR reaction.
The inactivation of PTS in E. coli causes a strong re-
duction in qGlc and μ, therefore, such mutant strains dis-
play a PTS- glc- phenotype. To improve qGlc and μ,
strain VH33 has a chromosomal modification that
increases its capacity for non PTS-dependent glucose
transport and thus displays a PTS- glc+ phenotype. In
strain VH33 glucose phosphorylation is not dependent
on PEP; instead, ATP is the phosphate donor in a reac-
tion catalyzed by glucokinase. The μ of the PTS- glc-
progenitor strain VH32 is 0.03 h-1, whereas this value
increased to 0.45 h-1 in VH33 as a result of replacing the
native promoter of gene galP with the strong promoter
trc [50]. In this study, the qGlc of strain VH33 was deter-
mined and it corresponded to 43% of that measured in
wild-type W3110. An expected consequence of the lowerqGlc in VH33 is a decreased flux in the EMP pathway.
The flux analyses performed in this report revealed that
the main observed response to PTS inactivation was flux
rerouting at the AcCoA node, resulting in a highly
reduced qAc. This metabolic response is expected to
compensate for the reduced glycolytic flux in strain
VH33, diverting the AcCoA not consumed for acetate
production mainly into the TCA cycle. The net result is
an augmented flux into the TCA cycle with an expected
increase in the synthesis rate of biomass precursors
αKGT and OAA, as well as reduced cofactors that can
lead to ATP synthesis by oxidative phosphorylation. In-
activation of either PykA or PykF in the PTS- glc+ back-
ground caused an approximately further 50% reduction
in qGlc and flux in the PEP to PYR reaction when com-
pared to data from VH33. These results indicate that
both isozymes should be active to sustain the high flux
level in this part of the EMP pathway when E. coli grows
on glucose. Acetate production was not detected in
strains VH34 and VH35. In these strains, the relative
flux to the TCA cycle was higher than that observed for
W3110 but lower than the value for VH33. A second
observed response to PTS or PTS and Pyk inactivation
consisted in flux rerouting in the central metabolic network
leading to increased flux to biomass generation. The flux
value to biomass was nearly twofold higher in strains VH34
and VH35, when compared to VH33. This metabolic re-
sponse can be expected to have the effect of conserving the
reduced amount of intermediate metabolites resulting from
the diminished glucose import and catabolism capacity in
the PTS- and Pyk- mutant strains. As expected, the flux
values leading from the central metabolic pathways to bio-
mass formation showed a positive correlation with the
observed Yx/s in all studied strains.
Evidence of cycling via Ppc and Pck was detected in
the wild-type strain W3110. This metabolic cycle has
also been reported by other authors in wild-type E. coli
[26,27]. A comparison among the mutant strains gener-
ated in this study provides the opportunity to explore
the role of this cycle in E. coli. Flux analysis revealed that
PTS inactivation causes an increase in the cycle net flux.
A similar response is observed by simultaneous PTS and
PykF inactivation (strain VH35). In contrast, the lowest
net flux value was observed in strain VH34 that lacks
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verse correlation between qs and the net flux in this meta-
bolic cycle, which can be observed when comparing strains
W3110, VH33 and VH35. It is not clear why this correl-
ation does not apply for strain VH34. This might be related
to the differential effects of PykA or PykF inactivation on
the metabolic flux distribution around the PEP node. In a
previous report, when comparing a wild-type strain and a
derivative lacking both PykA and PykF activities, the Pyk
double mutant displayed a higher cycle net flux [26]. How-
ever, in this case, the qGlc of the strains were similar, so the
observed effect must be mainly related to the reduced flux
in the PEP to PYR reaction.
The ATP/ADP ratio is an important physiologic param-
eter that modulates several cellular functions. It has been
observed that a reduction in the ATP/ADP ratio, caused by
increasing ATP hydrolysis activities, stimulates flux in the
EMP pathway [58]. Each cycle involving Ppc and Pck activ-
ities consumes one ATP molecule. Thus, a reduction in the
cellular ATP/ADP ratio could be expected at high Ppc-Pck
cycle flux values, and this could stimulate EMP pathway
flux. The observed inverse correlation between qGlc and the
net cycle flux in strains W3110, VH33 and VH35 suggests
this cycle might be contributing to increasing EMP pathway
flux and thus, growth capacity in the mutant strains. To test
this hypothesis, mutant derivatives of strains W3110,
VH33, VH34 and VH35 lacking Pck activity were con-
structed and characterized. A reduction in qGlc and μ was
observed in all derivative Pck- strains, suggesting that the
Ppc-Pck cycle's function is related to stimulating flux in the
EMP pathway.
Some of the metabolic responses discussed above, that
include qGlc reduction and flux rerouting at several
points in central metabolism can be partially explained
considering that PEP has a role in the allosteric regula-
tion of several enzymes of the EMP pathway. In
addition, inhibition of glucokinase by PEP has been
reported [9]. Considering the genetic modifications per-
formed, a larger PEP pool would be expected in strains
VH33, VH34 and VH35 when compared to W3110. This
assumption is consistent with the higher metabolic PEP
availability demonstrated in PTS- glc+ strains that have
been shown to produce aromatic compounds with a
higher yield from glucose and with data from PTS- Pyk-
mutats that will be discussed below [23,30].
Strains W3110A, VH33A, VH34A and VH35A carry
plasmids with genes encoding enzymes that increase car-
bon flow into the common aromatic and the PHE bio-
synthetic pathways (Figure 2a and Table 3). When
considering the YDHS+SHIK+PHE/Glc from resting cells
experiments in minimal medium with glucose, it can be
observed, as expected, that PTS inactivation causes an
increase in this parameter. In the PTS- glc+ background,
inactivation of PykA (VH34A) or PykF (VH35A), wouldbe expected to further increase PEP availability for aro-
matics biosynthesis. However, the YDHS+SHIK+PHE/Glc
value was lower in these two strains when compared to
VH33A. These results can be explained considering that
in strains VH34 and VH35 a higher flux value is directed
from central metabolism to biomass formation when
compared to VH33. In strains VH34 and VH35, an in-
verse correlation was observed between Yx/Glc and YDHS
+SHIK+PHE/Glc. These data indicates that a carbon-
limitation state in minimal medium with glucose reduces
PEP availability for aromatics production in strains
VH34 and VH35 as a result of competition for central
metabolic precursors, including PEP, between biomass
formation reactions and the modified aromatic pathways
in stains VH34A and VH35A. Consumption of precur-
sors for biomass synthesis from central metabolism
could be reduced in these two strains if they are
provided in the culture medium. When resting cells
experiments were performed in minimal medium sup-
plemented with yeast extract (10 g/l), a 19, 14 and 25-
fold increase was observed in VH33A, VH34A and
VH35A in YDHS+SHIK+PHE/Glc values when compared
with W3110 (data not shown). In addition, two reports
have shown that strains with PTS- glc+ PykA- or PTS-
glc+ PykF- phenotypes display higher production cap-
acity for aromatic compounds in complex media when
compared to an isogenic PTS- glc+strain [17,22].
It has been shown that a strain having the same pheno-
type as VH33 displays a better production performance
for recombinant protein production when compared to
W3110 [50]. This result can be explained by the lower
qAc and higher Yx/Glc displayed by the PTS
- glc+ mutant,
when compared to the wild-type strain. In this regard, it
is noteworthy that inactivation of either Pyk isozyme in
VH33 caused a further reduction in YAc/Glc to the point
where this organic acid was not detected by HPLC. Inter-
estingly, strain VH34 displayed no acetate production, a
66% increase in Yx/s over VH33 and the same μ. In a recent
report, strain VH34 transformed with a plasmid DNA vac-
cine (pDNA) and grown in complex medium supplemented
with glucose produced 50% less acetate and nearly 4-fold
more pDNA when compared to strain VH33/pDNA [59].
These data shows that strain VH34 has advantageous char-
acteristics for a microbial host that could be employed for
the development of fermentative process for plasmid DNA
or recombinant protein production.
Conclusions
In this study, the contribution of PTS and each of the Pyk
isozymes to the PEP to PYR flux as well as the conse-
quences of their inactivation on central metabolism were
determined by metabolic flux analysis. This work showed
that the presence of either one of the two Pyk isozymes
generates quite different physiological and central carbon
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to PTS or Pyk inactivation is consistent with central metab-
olism flux rerouting to compensate for the lower EMP
flux observed in these mutant strains. The detailed
characterization presented here provides further insight
into the flexibility of the central metabolic network in E.
coli and will be useful in the design of strategies for generat-
ing strains for the production of aromatic metabolites, plas-
mid DNA or recombinant proteins.
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